Imaging Genomics of Glioblastoma: State of the Art Bridge Between Genomics and Neuroradiology

摘要: Glioblastoma (GBM) is the most common and aggressive primary malignant tumor of central nervous system. Recently, researchers concluded that "one-size-fits-all" approach for treatment GBM no longer valid research should be directed toward more personalized patient-tailored protocols. Identification molecular genomic pathways underlying essential achieving this targeted therapeutic approach. Imaging genomics represents a new era as noninvasive surrogate profile identification. This article discusses basics imaging GBM, its role in decision-making, future potential